Okay. Hello, everyone. Thanks for joining us today. I'm Ryan Weispfenning, Vice President and Head of Investor Relations at Medtronic. Thank you for joining call showcasing the Altaviva device, which ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...

Medtronic is an undervalued AI stock with an elite dividend program. Artificial intelligence (AI) is ushering in a new era of innovation that promises to upend industries across the spectrum, and the ...

By Sahil Pandey March 10 (Reuters) - Medical device maker Medtronic said on Tuesday it would buy U.S.-based Scientia Vascular ...

In early March 2026, Medtronic reported stronger-than-expected Q3 2026 results with 6% year-over-year organic revenue growth and affirmed a US$0.71 quarterly dividend per share, extending its 48-year ...

We recently published a list of 15 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other stocks on Jim Cramer’s radar. On ...

When it comes to medical devices, some of the most exciting ones, to me, are robotic surgical systems. Intuitive Surgical has been a leader in that arena, averaging annual gains of 19% over the past ...

You would think that the medical-device sector would be rife with big gainers thanks to an aging population, but it’s not quite as simple as that. Just as we saw when we examined the biotechnology ...

Medtronic has bought a stroke-treating device firm for $550 million as the Fridley-operated medtech company executes its growth strategy of mergers and acquisitions. Scientia Vascular launched the ...

Cybersecurity vulnerabilities in certain Medtronic CareLink programmers are at the center of the recent voluntary recall. (This story has been updated with an FDA statement.) See Also: A Legal ...